- California Serogroup Virus Diseases
- Candida auris, clinical
- Carbon Monoxide Poisoning
- CP-CRE, Enterobacter spp.
- CP-CRE, Escherichia coli (E. coli)
- CP-CRE, Klebsiella spp.
- Crimean-Congo Hemorrhagic Fever (CCHF) Virus
No results found
Nevada’s Authority for Epidemiology
Access up-to-date data on all active infectious diseases reported in Nevada.
Laboratory Reporting Negative HIV and HEP C Tests
Summary On Dec. 10, 2023, the Nevada Legislative Commission approved amendments to the Nevada Administrative Code (NAC) 441A that updated reporting requirements for both hepatitis C virus (HCV) and human…
Updates to NAC 441A, Regarding Reportable Communicable Diseases in Nevada
Background On Dec. 10, 2023, the Nevada Legislative Commission approved amendments to Nevada Administrative Code (NAC) 441A that updated the conditions which are mandated to be reported in Nevada. These…
CDC Provides New Laboratory Recommendations for Syphilis Testing
Introduction Currently, no available nucleic acid amplification tests (NAATs) are cleared by Food and Drug Administration (FDA) for marketing in the United States to screen or diagnose syphilis, and culture…
Candida auris regulation changes
Background Candida auris (C. auris) is a newly emerging biological fungal agent that can cause severe illnesses. It is known to be resistant to most antifungal treatments and can spread…
Concerning Tuberculosis Trends and Guidance to Identify and Eliminate Tuberculosis
Summary of Concerning Tuberculosis Trends in Nevada To eliminate TB, Nevada’s public health systems in collaboration with health care providers need to increase identification of individuals at risk for TB,…
National Shortage of Erythromycin 0.5% Ophthalmic Ointment (erythromycin)
Gonorrhea ocular prophylaxis of newborns is mandated by law and is considered standard neonatal care in Nevada. Nevada Revised Statute (NRS) 442.050 and NRS 442.060 require every “physician or midwife…